Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

NCT01868555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: insulin degludec
DRUG: insulin degludec/insulin aspart 30
DRUG: insulin degludec/insulin aspart 45
DRUG: placebo

Sponsor

Novo Nordisk A/S